在RUNX1和SRSF2突变背景中破坏bZIP域的异合体CEBPA突变导致MDS疾病进展
Ruba Almaghrabi1,2, Yara Alyahyawi1,3, Peter Keane4
1Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK.
Nature communications
|July 2, 2025
概括
突变的CCAAT增强剂结合蛋白α (CEBPA) 驱动肌肉发育综合征 (MDS) 进展到急性髓性白血病 (AML). 这项研究为开发新的诊断和治疗策略提供了一个新的异构性MDS模型.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 骨髓质疏松症候群 (MDS) 的特征是突变导致急性骨髓性白血病 (AML) 进展的风险变化.
- CEBPA突变与高风险的MDS有关,但它们在AML发展中的直接作用仍然不确定.
研究的目的:
- 调查MDS疾病进展背后的分子机制.
- 为了确定CEBPA突变是否导致AML的发展.
- 建立一个新的MDS研究和药物查的实验模型.
主要方法:
- 由患有RUNX1/SRSF2突变的低风险MDS患者产生的患者衍生诱导多能干细胞 (iPSC).
- 在这些iPSC中引入了C/EBPα bZIP域中的移突变.
- 分析了血液形成的分化,细胞组成 (单细胞RNAseq) 和染色体格局的变化.
主要成果:
- 生成的iPSC模型在血液构成差异化后重复了MDS表型.
- 引入CEBPA突变模仿了疾病的进展,减少了髓状细胞的克隆性,并阻断了颗粒形成.
- 这种突变改变了染色质格局和细胞组成,证实了它的致病作用.
结论:
- 突变CEBPA是MDS疾病向AML进展的绝对原因.
- 这项研究提出了一个有价值的异构性MDS模型,用于评估新的治疗策略和改进诊断.
相关概念视频
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
Incomplete Dominance
25.6K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
25.6K
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K


